You have 9 free searches left this month | for more free features.

Relapse-Free Survival

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

Completed
  • Acute Lymphoblastic Leukemia
    • Brno, Czechia
    • +9 more
    Sep 12, 2022

    Biochemical Relapse Free Survival, Complications Rates (Erectile Dysfunction, GI, GU Complications) Trial in St Petersburg

    Recruiting
    • Biochemical Relapse Free Survival
    • Complications Rates (Erectile Dysfunction, GI, GU Complications)
    • Stereotactic ablative radiotherapy
    • High dose rate brachytherapy
    • St Petersburg, Russian Federation
      Sergey Novikov
    Apr 28, 2021

    Prognostic Factors Affecting Recurrence and Disease-Free

    Recruiting
    • Rectal Cancer
    • curative surgery for cancer rectum
    • Qinā, Egypt
      Qena Faculty of Medicine, South Valley University Hospitals
    Oct 21, 2023

    Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • (no location specified)
    Mar 6, 2023

    Severe Toxicity Free Survival Following Childhood Acute

    Recruiting
    • Acute Lymphoblastic Leukemia
      • Copenhagen, Denmark
        Kjeld Schmiegelow
      Dec 9, 2022

      Crestal Bone Loss, Survival Rate Trial in Cairo (placement of dental implants)

      Completed
      • Crestal Bone Loss
      • Survival Rate
      • placement of dental implants
      • Cairo, Egypt
        Ain Shams University
      Oct 21, 2023

      Improving Liver Transplant-free Survival in Acute Decompensation

      Not yet recruiting
      • Decompensated Cirrhosis
      • No intervention
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Jul 12, 2023

      Ovarian Cancer Trial in Roma (Blood samples)

      Not yet recruiting
      • Ovarian Cancer
      • Blood samples
      • Roma, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Oct 3, 2023

      Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Neoadjuvant
      • Axitinib plus Toripalimab
      • radical nephrectomy
      • (no location specified)
      Feb 12, 2023

      Disease-free Survival of High-risk Head-neck Cutaneous Squamous

      Active, not recruiting
      • Carcinoma, Squamous Cell
      • +5 more
      • Treatment
      • Maastricht, Netherlands
      • +1 more
      Apr 26, 2023

      Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

      Recruiting
      • Prostate Cancer
      • +2 more
      • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
      • +7 more
      • Quebec, Canada
        CHUdeQuebec
      Apr 7, 2023

      Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

      Completed
      • The Primary Study Metric is Progression-free Survival (PFS)
        • (no location specified)
        Jun 28, 2023

        Smoking, Tobacco Use, Lung Cancer Trial in Tampa (Nicotine patch and lozenges, Telephone counseling sessions, Access to a

        Active, not recruiting
        • Smoking
        • +2 more
        • Nicotine patch and lozenges
        • +3 more
        • Tampa, Florida
          Moffitt Cancer Center
        Jan 9, 2023

        Textbook Outcome in Colon Carcinoma

        Completed
        • Outcome Assessment
        • Cancer of Colon
        • Colon oncological resection
        • Alicante, Spain
          Hospital General Universitario Dr. Balmis
        Jan 5, 2023

        Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)

        Recruiting
        • Meningioma
        • +2 more
        • Biological biomarker assessment
        • Rome, Italy
          Fondazione Policlinico Universitario A. Gemelli IRCCS
        Mar 29, 2023

        Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

        Recruiting
        • Stem Cell Transplant Complications
        • +4 more
        • Radiation
        • +7 more
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Jan 19, 2023

        to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

        Recruiting
        • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
        • Capecitabine 500Mg Oral Tablet
        • Shanghai, China
          Eye & ENT Hospital, Fudan University
        Jul 2, 2023

        Overall Survival, Progression-free Survival, Cost Trial (Microwave Ablation)

        Completed
        • Overall Survival
        • +2 more
        • Microwave Ablation
        • (no location specified)
        Apr 1, 2023

        Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

        Active, not recruiting
        • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
        • Seoul, Korea, Republic of
          Asan Medical Center, University of Ulsan College of Medicine
        Oct 19, 2023

        Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)

        Active, not recruiting
        • Primary Non-metastatic Breast Cancer
        • Who Remain Disease-free
        • Lyon, France
        • +1 more
        Feb 23, 2022

        Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

        Terminated
        • Breast Neoplasms
        • Saint Louis, Missouri
          Washington University School of Medicine
        Oct 31, 2022

        Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

        Recruiting
        • Disease Free Survival
        • +2 more
        • use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
        • Milan, Italy
          IRCCS San Raffaele
        Mar 7, 2022

        Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)

        Not yet recruiting
        • Progression-free Survival
        • Sovalteinib Solutumab Tegeo
        • (no location specified)
        Jul 24, 2023

        Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

        Recruiting
        • Prostate Cancer
        • +6 more
        • Radiotherapy (SBRT) and/or surgery (metastasectomy)
        • +2 more
        • Leuven, Belgium
          University Hospitals Leuven
        Jun 7, 2022

        Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)

        Terminated
        • Bladder Cancer
        • Bladder Urothelial Carcinoma
        • re-TURBT
        • 6 weeks BCG instillation
        • Toronto, Ontario, Canada
          University Health Network
        Apr 12, 2022